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Following a one-month prospective study of antimicrobial drug use in surgical 
departments, new guidelines were implemented. The review was repeated after two 
years. In both study periods, one third of patients were prescribed antimicrobial 
drugs. Prophylactic antibioticconsumption decreased from 0.75 to 0.53 defined daily 
doses/operation. Compliance with guidelines improved from 32% to 79%. Duration 
of prophylaxis >24 h decreased from 21% to 8%. Single dose prophylaxis increased 
from 34% to 80%, Quality of the prophylactic courses improved, as evaluated by 
experts using established criteria. For prophylaxis, cost savings amounted to 57%. 
Better quality of therapeutic courses was associated with a cost increase of 15%. 
Indicators of satisfactory outcome with the new policy were a stable median length 
of stay (5.5 days in the first review and 5,0 days after intervention) and a reduction 
in the number of nosocomial infections treated with antimicrobial drugs/100 bed 
days (1.0 before intervention vs 0.77 after intervention).
Introduction
Antimicrobial drugs account for 13-37% of the drug budget in European hospitals 
(Hekster & Barrett, 1987); 30-60% of the courses are for prophylactic use (Maki & 
Schuna, 1978; Nickman, Blissenbach & Herrick, 1984), The main reasons for 
monitoring antimicrobial drug use are to optimise medical care, to limit and reduce the 
spread of resistant microorganisms and to contain costs. In Europe, the pressure to 
reduce costs is still increasing in countries with budgeting systems, such as in the 
Netherlands. In addition to a concern about increasing costs of antimicrobial drugs, 
many authors have described inappropriate use (Kunin et al,, 1990; Dimagan et al
1991), Surgical prophylaxis with antimicrobial drugs is long known as an area where
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overuse is often found and where it is also the easiest to correct (Smith et al., 1988; 
Galandiuk et al., 1989). Many antimicrobial drugs intervention strategies are described 
to optimise quality at lesser cost, including the development of protocols (Marr, Moffet 
& Kunin, 1988), A number of criteria for optimal therapy and prophylaxis are well 
established (Kunin, Tupasi & Craig, 1973; Gyssens et al., 1992), A widely accepted 
regimen of preoperative prophylaxis is 1 g of the first generation cephalosporin 
cephazolin, given within an optimal period before incision, and repeated if the operation 
lasts for more than 3 h (Abramowicz, 1989; Classen et al., 1992). We conducted a 
prospective intervention study in three surgical departments in a large university 
hospital: to define antimicrobial drug use (prophylaxis and therapy) in terms of quality 
and costs; and to measure the effect of interventions to improve the quality of 
antimicrobial drug courses.
Patients and methods
Setting
The University Hospital Nijmegen is a 948-bed teaching hospital with 344 surgical beds, 
and approximately 1600 operations/month on in-patients. The study took place in the 
departments of gynaecology and obstetrics (G), surgery (S) and orthopaedic surgery 
(O). The hospital formulary listed 20 parenteral and 26 oral antibacterial drugs at the 
start o f the study. In the previous year, antimicrobial drugs accounted for 22% of the 
hospital drug budget of Dfl 14 million (£5.3 million). The Antibiotics Committee had 
issued a new edition of an antimicrobial drug formulary. In addition, some surgical 
departments had their own treatment protocols. We refer to both as ‘guidelines’. The 
classification of Cruse & Foord (1980) for surgical procedures was used with 
adaptations (Abramowicz, 1989). Length of stay was calculated as follows: number of 
in-hospital days of patients included in the study/number of patients included in the 
study.
Antimicrobial drug use review
The first review took place during separate one-month study periods in 1990. 
Antimicrobial drug use was reviewed in 766 consecutive surgical patients. After a period 
of intervention, a similar review of 744 consecutive patients was repeated in 1992. The 
studies were performed by an infectious diseases physician and junior clinical 
pharmacists, who collected data daily on all patients receiving antimicrobial drugs. 
Abstracts were made o f each course. A course was defined as an episode of clinical or 
suspected infection or increased risk of infection, in which prescription(s), either 
consecutively or in combination, were written as treatment or prophylaxis. Clinical 
information was retrieved from the patients’ records. Infections were defined according 
to the Centers of Disease Control (Garner et a i ,  1988). Nosocomial infection was 
defined as active infection that was not present or incubating at the time of admission. 
Microbiology results were obtained directly from the laboratory. The schedule of 
systematic antimicrobial drug treatment was copied from the medication chart and from 
the anaesthesia record.
Antimicrobial drug use was converted into Defined Daily Doses (DDD). The DDD 
represents the average therapeutic dose for an adult for the standard indication
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(Anonymous, 1982). Quantitative use was analysed by calculating the num ber of 
courses in the population at risk in the study periods (courses/100 bed days, incidence 
rate) and by comparing D D D /100 bed days. The D D D /100 bed days has been chosen 
by the WHO Drug Utilization Research Group as a unit of comparison between 
hospitals (Bergman et a l 1979). Direct and indirect costs were calculated in Dutch 
guilders (Dfll =  £0.38) by a method for global drug cost calculation, which includes 
costs of drug administration and costs of monitoring (Gyssens et a l ., 1991),
Qualitative use was analysed in two ways. First, compliance with existing hospital 
guidelines was checked at the time of the initial review, and compliance with the 
department’s new protocol after the intervention. Second, two independent experts in 
infectious diseases (termed reviewer 1 and reviewer 2) evaluated quality in the following 
way: prescriptions were assessed using six categories of antimicrobial use by means of 
established criteria arranged in a flow chart. The method is based on the original criteria 
of Kunin et al. (1973) and is described previously (Gyssens et a l 1992). In short, 
prescriptions can be definitely appropriate (category I), unjustified (category V) or the 
records insufficient for categorization (category VI). The other prescriptions are placed 
in categories of inappropriate use II, III, and IV. Inappropriate prescriptions can be 
allocated to several categories at the same time: incorrect dose (Ila), interval (lib) or 
route (lie), duration too long (Ilia) or too short (Illb). If relevant, the experts cite a 
better alternative agent for reasons of optimal effectiveness (using microbiological and 
pharmacodynamic criteria) (category IVa), lower toxicity (IVb), lower cost (IVc) or less 
broad spectrum (IVd). Global costs of actual and alternative policies (in this study the 
alternative policy proposed only by reviewer 1) were compared in order to estimate 
savings due to changes in policy. Reviewer 1 was chosen in this context for both 
simplicity and because he was the infectious diseases expert of the study centre.
Intervention
After the first review, reports were sent to the heads of each department. The report 
was accompanied by recommendations for the alternative antibiotic policy of reviewer
1, in accordance with the antimicrobial drug policy. The principal goal was to introduce 
a universal surgical prophylaxis standard of single-dose cephazolin at incision (with 
metronidazole if necessary to provide anti-anaerobe activity). The recommendations 
were adapted to new protocols with the help of a surgical staff member. After approval 
by the Antibiotics Committee, a presentation was held in the department, aided by the 
surgical staff member. In most departments, the first dose of antimicrobial prophylaxis 
was given by the anaesthetist in the operating room. Because anaesthesias were 
performed by a rotating pool of 40 anaesthetists (staff and residents), the departm ent 
of anaesthesiology was interviewed by means of a questionnaire. The inquiry showed 
deficient communication between anaesthetists and surgeons on the subject of 
administration and timing of antibiotic prophylaxis (Gyssens, Knape & Van der Meer, 
1995). The results of the inquiry were reported in an educational setting.
Implementation of the protocols was assisted by the department o f clinical pharmacy. 
Junior pharmacists organized briefings for nurses, and the prophylaxis guidelines were 
displayed in the wards and operating rooms. Operating room drug stocks were 
reorganized. In departments S and O, pharmacy technicians discussed protocol 
violations with prescribers and nurses on their twice weekly visits to the wards, as a long 
term surveillance exercise.
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Statistical analysis
Generally, chi-squared tests were applied to establish systematic differences. The 
Wilcoxon test was used for the comparison of lengths of hospital stay. Fisher’s exact 
test was used to compare durations of prophylaxis. Agreement between the experts was 
assessed by k  coefficients.
Results
Quantitative use
Table I shows the characteristics of the study populations in the first and second study 
periods. The numbers of patients hospitalized and operations performed in the study 
periods, and the proportions of patients given antimicrobial drugs were similar in both 
reviews. The median length of hospital stay in the two study periods was not statistically 
different in departments G and S. In department O, the median length of stay decreased 
significantly (P — 0.005). Mean patient age was 40.9 (range 2-88) and 43.4 (range 0-94) 
before and after the intervention, respectively. The proportion of parenteral antibiotic 
D D D s increased from 62% to 80%. Quantitative data were analysed in detail according 
to prophylaxis and therapy.
Prophylaxis. Thirty-nine prophylactic courses/100 operations were performed after 
intervention, compared with 34 courses/100 operations in the first review. However, the 
use o f  prophylactic antimicrobial drugs expressed in DDD/operation decreased. After 
the intervention, only 16% of total use (in DDDs) was for prophylactic use, compared 
with 31% in the first review. Before intervention, a variety of antimicrobial drugs were 
used for prophylaxis in regimens lasting 24 h (Figure 1).
W hen the medication order on the anaesthesia record mentioned “24 h” , some nurses 
in the wards did not take into account the antibiotic dose given by the anaesthetist in 
the operating room. This practice resulted in an extra dose in 10% (department O) and 
in 50% (department S) of the prescriptions for 24 h of prophylactic antibiotics. After 
the intervention, fewer regimens were used in favour of a single dose of cephazolin 
(plus metronidazole).
Therapy. Therapeutic courses/100 bed days decreased from 2.1 to 1.8. Abdominal 
(37%) and pelvic (40%)) infections were the most frequent type of infections treated with 
antibiotics in both reviews. Urinary tract infections accounted for 23% and 24% of 
infections in the two study periods. The number of nosocomial infections treated with 
antimicrobial drugs/100 bed days was 1.0 before intervention and 0.77 after 
intervention. There was an increase of DDD/therapeutic course from 8.8 to 17.1. The 
main reason for the increase was that the new protocols advised treatment of severe 
infections, such as osteomyelitis, with larger dosages and for longer periods.
The major changes in the therapeutic antimicrobial drugs prescribed are presented 
in Table II. After the intervention, narrow spectrum penicillins (penicillin G, 
flucloxacillin) were used more often in directed therapy. Penicillin use increased 
four-fold and prescription of iv cephalosporins increased by half. However, some 
changes occurred unexpectedly; for example, amoxycillin-clavulanate had been 
introduced in the new protocol of department G for the treatment of post-partum
Table I. Demographics of three surgical departments and antimicrobial drug use (two separate one-month reviews)
Before intervention After intervention
Department Ga S* Oc Total G S O Total
number of patients 331 286 149 766 282 302 160 744
Number of operations 150 258 134 542 144 245 133 522
clean 104 112 73 289 94 115 84 293
clean/prosthesis 46 51 97 46 43 89
contaminated 46 47 93 50 52 102
dirty 53 10 63 32 6 38
Median length o f stay, days (range) 2.5 (1-42) 7.5 (1-232) 9 (1 -9 2 / 5.5 (1-232) 2.5 (1-52) 7 (1-172) 6 ( 1 -60)" 5 (1-172)
Bed days 1586 2292 1199 5077 1284 2373 1085 4742
Total number o f antibiotic courses 82 129 79 290 68 149 71 288
Prophylactic antibiotic courses 52 78 55 185 53 96 53 202
Therapeutic antibiotic courses 30 51 24 105 15 53 18 86
Total consumption, D D D e 352 655 320 1327 340 835 574 1749
Prophylactic DDD/operation 0.91 0.65 0.76 0.75 0.78 0.45 0.41 0.53
Therapeutic D D D /100 bed days 13.6 20.9 18.2 18.1 17.7 30.6 47.9 31.0
^Gynaecology and obstetrics; ^Surgery; fOrthopaedic surgery; dP — 0.005, Wilcoxon test; '’Defined Daily Dose.
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Figure 1. Use of antimicrobial drugs for surgical prophylaxis before (a) and after (b) an intervention in 
departments o f  Gynaecology and obstetrics H, Surgery Ú and Orthopaedic surgery
endometritis only. In the second review, amoxyciliin-clavulanate use had increased 
from 0 to 6.9 DDD/100 bed days and represented 39% of the departments’ total 
therapeutic use. 
Costs 
Total (global) costs amounted to Dfl 37,448 (£14,131) before the intervention and to 
Dfl 33,289 (£12,562) in the second review, resulting in total cost savings of 11%. 
Projected annual savings amounted to Dfl 49,800 (£18,792).
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Table II. Use of antimicrobial drugs for therapy (DDD/100 bed days) by three surgical
departments. See Table I for legend
Before intervention After intervention
Department G S O total (%) G S O total (%)
Penicillins 2.8 6.6 1.4 4.2 (23) 8.0 13.5 39.4 18.0 (58)
Cephalosporins 1.6 2.3 8.3 3.5 (19) 2.3 7.4 3.8 5.2 (17)
Gentamicin 0.4 3.0 1.5 (8) ---------- 2.1 1.1 (3)
Clindamycin 1.7 2.3 1.3 (7) ---------- 0.9 0.2 (1)
Doxycycline 4.0 0.3 1.3 (7) 1.6 0.4 (1)
Metronidazole 4.0 2 4 --------- 2.4 (13) 3.5 3.0 2.5 (8)
Co-trimoxazole 2.9 1.9 1.8 (10) 1.2 2,7 1.4 2.0 (6)
Ciprofloxacin ---------- --------- --------- 0.6 0.2 0.3 (1)
Miscellaneous 0.8 2.3 3.8 2.2 (12) 1.1 1.3 2.2 1.4 (5)
Total 13.6 21.2 18.2 18.1 (100) 17.7 30.6 47.9 31.0 (100)
Prophylaxis. The cost of prophylactic antibiotics was Dfl 13,376 (36% of the total 
antibiotic budget) in the first review and Dfl 5,725 (17%) after intervention. Figure 2 
presents the total distribution of costs of prophylaxis by antimicrobial drug group 
before and after the intervention. Before the intervention, piperacillin, which accounted 
for 7% of the antibiotic consumption of department G, accounted for 34% of costs. 
In department S, clindamycin, which accounted for 16% of total use, accounted for 
48% of costs. Potential savings in prophylaxis, calculated by the experts after the first 
review, were estimated at 83%. The savings realized in the second review am ounted to 
57%. Prophylactic cost/operation was halved, from Dfl 2.2 to Dfl 1.1. Savings were 
mainly realized by replacing piperacillin (Dfl 44.9/single dose) and the regimen of 
gentamicin with clindamycin (Dfl 107.6/24 h course) by cephazolin (Dfl 6.3/single dose) 
with or without metronidazole (Dfl 6.1/single dose).
Therapy, After the intervention, overall costs of therapy increased by 15%. This increase 
was mainly due to higher dosage and longer duration of treatment. The drugs o f the 
new protocol were often cheaper; after intervention, the cost/therapeutic D D D  had 
decreased from Dfl 26.1 to Dfl 18.7. Part of the costs were still due to inappropriate 
prescriptions.
Qualitative aspects
Prophylaxis. After intervention, there was a higher overall compliance with the new 
protocols than with the old guidelines (P < 0.0001) (Table III). The difference was 
significant in each of the three departments. Parameters of quality for prophylaxis 
improved; the use of a prophylactic course for > 2 4 h  decreased significantly in 
department S but not in departments G or O. Single dose prophylaxis increased 
significantly in each of the three departments. The intervention also improved the timing 
of the first dose of antibiotic (administration within 1 h before surgical incision) in 
departments S and O, as reported previously (Gyssens et a l 1996).
Agreement (excepting category VI) between the two experts assessing quality of 
prophylaxis before and after intervention was very high in both reviews ( k  =  0.80). 
Therefore, only the assessment of one expert, reviewer 1, is discussed here and is
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Figure 2. Costs in Dfl (Dfl 1 =  £0.38) of antimicrobial drugs for surgical prophylaxis before □  and after 
an intervention.
presented in Table III. There were significant differences in quality before and after the 
intervention in departments G (P < 0.0001), S (P <  0.0001) and O (P — 0.004).
Table IV shows most frequent type of errors (evaluation categories II-V) by 
prophylactic drug before intervention. Oral cephalexin prophylaxis started post-opera- 
tively and continued for five days was considered unjustified (category V). Oral 
prophylaxis with neomycin/bacitracin was followed by iv gentamicin plus clindamycin 
at induction of anaesthesia in 15 of 28 courses. The oral prescriptions were judged 
unnecessary (category V). Moreover, the review revealed some erroneous practices. In 
department S, nurses administered neomycin/bacitracin to all patients undergoing a 
bowel purging procedure, including those patients due to have anorectal operations 
(category V). Most oral prophylaxis (use of oral plus iv regimens or postoperative) was 
abandoned after the intervention. Prophylaxis with piperacillin was considered to be too
Table III. Quality parameters of antimicrobial drug prophylaxis in three surgical departments.
See Table I for legend
---------------------- -------------------------- ---------------- --------------------------------------------------------------------  ■ — ----------------
Before intervention After intervention
Department G S O total G S O total
Num ber of prophylactic courses'7 52 78 55 185 53 96 53 202
According to guidelines (%) 15 32 47 32a 66 90 74 79"
D uration > 2 4 h  (%) 27 23* 11 21 15 3fr 9 8
Single dose (% ) 58 21 31 34‘‘ 77 78 85 80c
Evaluation by reviewer 1
Prophylactic prescriptions'' 91 113 61 265 110 141 52 303
Definitely appropriate (cat I) (%) 1 10 43 15 59 73 73 68
Unjustified (cat V) (%) 63 22 36 39 21 4 10 11
Inappropriate (cat II—III—IV) (%) 36 64 21 44 18 22 15 20
Unevaluable (cat VI) (%) 0 4 0 2 2 1 2 1
a'cP <  0.0001, x2 test; bP <  0.0001, Fisher’s exact test.
‘'See “ Patients and methods” for definitions of courses and prescriptions.
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Table IV. Quality evaluation of 265 prophylactic antibiotic prescriptions in three surgical departments
before intervention
Prophylactic
antibiotic
Number of 
prescriptions
Total
(Dfl)
Most frequent 
type of error"
Number (%) of 
unjustified 
prescriptions 
(category V)
Cost
avoidance
Dfl (%)
Cephalexin 17 364 V 15 (88) 307 (84)
Cephazolin 88 3401 V, Ilia 35 (40) 1028 (30)
Cefuroxime 9 203 V 3 (33) 58 (29)
Clindamycin 26 4247 IVc, Ilia 3 (12) 496 (12)
Gentamicin 33 1757 IVa,b,c, Ilia 7 (21) 196 (11)
Metronidazole 9 265 V, Ilia 4 (44) 152 (57)
Neomycin/bacitracin 28 610 V, lib, IVa 15 (54) 331 (54)
Piperacillin 31 1392 IVc,d 14 (45) 628 (45)
Miscellaneous 24 1138 V 8 (33) 519 (46)
Total 265 13377 104 (39) 3715 (28)
"Category Mb, incorrect dosage frequency; category Ilia, too long; category IVa, alternative agent 
more effective; category IVb, alternative agent less toxic; category IVc, alternative agent less expensive; 
category IVd, alternative agent less broad spectrum; category V, unjustified.
broad and expensive (category IV c, d). Overall, 39% of prophylactic prescriptions were 
judged unjustified. Their cost represented 28% of total cost of prophylactic antibiotics 
(Table IV) and 66% of the predicted cost savings with the alternative policy proposed 
by reviewer 1.
Therapy. Overall agreement between the two reviewers was much lower for therapy, 
both before (ic =  0.37) and after (k =  0.30) intervention. New protocols were based on 
the alternative policy of reviewer 1. Considering the overall evaluation of 224 and 169 
therapeutic prescriptions of the three departments, before and after intervention by 
reviewer 1, respectively, the proportion of prescriptions that were considered definitely 
appropriate (category I) increased from 70 (31%) to 80 (47%). Prescriptions unjustified 
for therapy (category V) decreased from 35 (16%) to 14 (8%). Inappropriate 
prescriptions accounted for 100 (45%) and 61 (36%), respectively (P  = 0.007).
Discussion
From the initial review we concluded that antimicrobial drug use in the surgical 
departments could be improved both in terms of quality and costs. In our hospital, 
major misuse such as prophylaxis >48  h or a combination of more than three 
antibiotics (Kunin et al., 1973) was seldom encountered. Non-compliant physicians 
were rare.
The intervention succeeded in implementing a widely accepted regimen o f  single dose 
antibiotic (cephazolin ±  metronidazole) for surgical prophylaxis. This type of 
intervention has been successful in departments of gynaecology and obstetrics (Smith 
et a l 1988; Everitt et al., 1990). The contribution of parenteral clindamycin to costs 
is considerable (Kunin, 1985), and its replacement by metronidazole is known to be 
cost-containing (Fletcher et a l 1990). We implemented the regimen in several surgical 
specialties for all procedures where prophylaxis was deemed appropriate. The 
intervention included the education of anaesthetists, nurses and  surgeons. The
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preparation and acceptance of the new guidelines took several months. At 
implementation, however, the effect was sometimes immediate, for example, by 
changing the operating room drug stock. The regimen replaced a variety of broad 
spectrum antimicrobial drugs, previously chosen on the basis of personal preferences 
and possibly the result of promotional efforts by pharmaceutical companies. 
Prophylaxis with cephazolin was generally cheaper, even in combination with 
metronidazole (Gyssens et a l., 1991). Cost-containment was also obtained by shortening 
the duration of prophylaxis. Compliance with guidelines improved, as did the result of 
the evaluation by the experts. Both reviewers largely agreed upon the improvement of 
quality of prophylaxis.
Improvement in the quality of therapeutic antibiotic prescribing was less striking, and 
was achieved at higher cost. There was limited agreement between the two experts 
concerning the quality of surgical therapy. Reviewer 2 judged less therapeutic 
prescriptions appropriate and more prescriptions unjustified, both before and after the 
intervention. However, his assessment also changed significantly after the intervention 
(data not shown). Correction of undertreatment of severe infections increased costs.
Reviews o f this type are time consuming. However, the in-depth analysis detected 
m any logistic problems, solutions to which seemed crucial for the successful 
implementation of adequate prophylaxis. Organizational aspects were of major 
importance, as others described recently in the U K  (Dobrzanski et a l., 1991). The 
in-depth analysis also detected problems with specific antibiotics. We used D D D s as 
a unit of measurement to allow international comparison o f the utilization data. 
However, the main problem with DDDs in hospitalized patients is that the Prescribed 
Daily Dose (PDD) for certain antibiotics can be quite different from the D D D  
depending on the indication. When DDDs are used as a unit of measurement for single 
dose antibiotic surgical prophylaxis low usage figures result. For prophylaxis, the 
D D D /100 bed days underestimates the population exposed, whereas for severe 
infections the number o f patients treated with the antibiotic is overestimated. The latter 
may partly explain why in all surgical departments, due to previous underuse, 
therapeutic antibiotic use defined in DDDs increased, and yet the same proportion of 
patients were treated. The overall proportion of patients receiving prophylaxis increased 
slightly, but more o f  these prescriptions were judged appropriate. There was no 
systematic registration of wound infections during the study periods, and therefore we 
cannot fully assess the relative efficacies of prophylaxis regimens.
We conclude that this intervention resulted in an optimisation of the quality of 
prophylactic and therapeutic antimicrobial regimens in surgical departments at a lower 
cost. Indicators of satisfactory outcome with the new policy were a stable median length 
o f hospital stay and a reduction in the number of nosocomial infections treated with 
antimicrobial drugs/100 bed days.
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